Portfolio (Quarterly)
Guide ↗
Mirae Asset Global Investments Co., Ltd.
· CIK 0001569395| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 681 | — | DISC MEDICINE INC | — | 1,990.0 | $127K | — | +156.0 | +8.5% | $63.94 | — |
| 682 | BEAM | BEAM THERAPEUTICS INC | Healthcare | 5,313.0 | $127K | — | +382.0 | +7.8% | $23.83 | +25.0% |
| 683 | BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | 13,082.0 | $125K | — | +3K | +27.9% | $9.52 | -11.4% |
| 684 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 2,525.0 | $124K | — | +173.0 | +7.4% | $49.05 | +30.6% |
| 685 | KOD | KODIAK SCIENCES INC | Healthcare | 3,184.0 | $121K | — | +606.0 | +23.5% | $38.12 | -22.3% |
| 686 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 3,096.0 | $121K | — | +212.0 | +7.3% | $39.20 | -14.2% |
| 687 | SRPT | SAREPTA THERAPEUTICS INC | Healthcare | 5,466.0 | $119K | — | +374.0 | +7.3% | $21.76 | -28.5% |
| 688 | TLS | TELOS CORP MD | Technology | 27,795.0 | $116K | — | +4K | +16.5% | $4.19 | +3.8% |
| 689 | DAWN | DAY ONE BIOPHARMACEUTICALS I | Healthcare | 5,388.0 | $116K | — | +399.0 | +8.0% | $21.44 | +0.4% |
| 690 | BWA | BORGWARNER INC | Consumer Cyclical | 2,084.0 | $113K | — | +191.0 | +10.1% | $54.26 | +39.8% |
| 691 | ADMA | ADMA BIOLOGICS INC | Healthcare | 12,543.0 | $113K | — | +978.0 | +8.5% | $9.01 | -10.5% |
| 692 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 4,128.0 | $112K | — | +282.0 | +7.3% | $27.09 | -16.9% |
| 693 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 8,032.0 | $111K | — | +613.0 | +8.3% | $13.88 | +20.3% |
| 694 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 4,600.0 | $107K | — | +377.0 | +8.9% | $23.36 | -27.4% |
| 695 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 2,784.0 | $107K | — | +190.0 | +7.3% | $38.30 | -30.2% |
| 696 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 5,040.0 | $106K | — | +352.0 | +7.5% | $20.95 | +3.1% |
| 697 | GRAL | GRAIL INC | Healthcare | 2,033.0 | $105K | — | +139.0 | +7.3% | $51.68 | +19.0% |
| 698 | BLTE | BELITE BIO INC | Healthcare | 657.0 | $105K | — | +12.0 | +1.9% | $159.44 | -12.4% |
| 699 | AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | 3,056.0 | $103K | — | +222.0 | +7.8% | $33.83 | -18.9% |
| 700 | AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | 6,936.0 | $103K | — | +529.0 | +8.3% | $14.82 | +5.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
41.2%
Communication Services
12.3%
Consumer Cyclical
10.0%
Healthcare
8.1%
Financial Services
7.7%
Industrials
6.8%
Consumer Defensive
5.9%
Energy
3.6%
Utilities
2.1%
Basic Materials
1.2%